> WARNING TO EXPECTANT PARENTS WITH A FAMILY HISTORY OF TYPE 1 DIABETES
>  
> Participating in this study may put your infant at increased risk for Type 1
> diabetes
>  
> Issued by INFACT Canada June 20, 2002
>  
>  
> A research project ­ TRIGR - Trial to Reduce Insulin-Dependent Diabetes in the
> Genetically at Risk ­ is one of the largest paediatric trials in the world.
> This randomized controlled trial will determine if a delay of dietary exposure
> to intact foreign food proteins can reduce the risk of developing Type 1
> diabetes in children genetically predisposed to the disease. The purpose is to
> test the outcomes for Type 1 diabetes when infants are fed an infant formula
> with partially hydrolyzed cow¹s milk proteins or to a routine infant formula
> mixture with 30% partially hydrolyzed cow¹s milk protein.
>  
> The study subjects will be asked to wean their baby from breastmilk to a
> formula that will have reduced level of intact cow¹s milk proteins, or a
> higher level of intact cow¹s milk proteins. As this is a randomized study,
> they will not know which formula their infant is receiving. There are a number
> of reasons why one should not participate in this study.

<snip>

The rest of the warning can be found here:

http://www.infactcanada.ca/trigr.htm


There's a link from the Infact Canada home page.

-- Jodine Chase

             ***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html